Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07158515 · ClinicalTrials.gov registry record · NA
The Heart Health After Cardiac Treatment Study
A NA study of Cardiac Rehabilitation, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT07158515: Recruiting NA study of Cardiac Rehabilitation, sponsored by University of California, San Francisco.
NCT07158515 is a NA study of Cardiac Rehabilitation that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 100 participants, below the 158-participant average among 13 other Cardiac Rehabilitation trials with a reported enrollment target (37% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07158515, a NA study of Cardiac Rehabilitation, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to determine whether participation in a tailored cardiac rehabilitation program delivered in a safety net setting, compared to usual care referral to an outside cardiac rehabilitation program, results in greater participation in cardiac rehabilitation.
Primary Outcome
In each arm, the proportion of participants who attended at least 1 cardiac rehabilitation session will be calculated.
Conditions Studied
Interventions
- BEHAVIORAL Tailored cardiac rehabilitation
- BEHAVIORAL Referral to an external cardiac rehabilitation program
Study Locations (1)
California
- Zuckerberg San Francisco General Hospital - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-11-28 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
What NCT07158515 shows while recruiting
NCT07158515 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 158-participant average among 13 other Cardiac Rehabilitation trials with a reported enrollment target (37% lower).
The record links to 1 condition, with Cardiac Rehabilitation appearing as the primary indexed condition, and to 2 interventions - of which Tailored cardiac rehabilitation is the first listed.
NCT07158515 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07158515 about?
NCT07158515 is a clinical study titled "The Heart Health After Cardiac Treatment Study". The goal of this study is to determine whether participation in a tailored cardiac rehabilitation program delivered in a safety net setting, compared to usual care referral to an outside cardiac rehabilitation program, results in greater participation in cardiac rehabilitation.
What is the current status of trial NCT07158515?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-11-28. Estimated completion is 2027-12-31.
What conditions does trial NCT07158515 study?
This clinical trial studies the following conditions: Cardiac Rehabilitation.
What interventions are being tested in trial NCT07158515?
The interventions under investigation include: Tailored cardiac rehabilitation (BEHAVIORAL), Referral to an external cardiac rehabilitation program (BEHAVIORAL).
Who is sponsoring clinical trial NCT07158515?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07158515 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Rehabilitation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07158515's enrollment target sits among peer trials
100 8th of 13 higher than 6 of 13 other Cardiac Rehabilitation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiac Rehabilitation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Transition to Cardiac Rehabilitation (T2CR) to Address Barriers of Multimorbidity and Frailty
RECRUITING · NA
-
SMART to Optimize an Intervention to Maintain Health Improvements After Cardiac Rehabilitation
RECRUITING · NA
-
Using a mHealth Intervention to Promote Physical Activity in Phase III Cardiac Rehabilitation Clients
RECRUITING · NA
-
Cardiac Rehabilitation Mobile-Health Fall Risk Prevention Intervention
RECRUITING · NA
-
Designing and Assessing a Women Only Cardiac Rehabilitation (CARE) Program
RECRUITING · NA
-
A Study to Compare the Effectiveness of Different High-intensity Interval Training Programs in Cardiac Rehabilitation
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI